Site Search
Search Results
Media Advisory: Advocates to Urge State Lawmakers to Pass Biomarker Testing Bill at Annual Cancer Action Day
... travel to the General Assembly on Wednesday, April 16, to meet with lawmakers and ask for their support of House Bill 567 to increase access to biomarker testing. When someone faces a cancer diagnosis, biomarker testing may help their doctors determine the right therapy or treatment. It can save patients from enduring treatments that may not work, ...
Governor Ducey Signs Legislation to Increase Access to Innovative Testing that Can Match Patients with Most Effective Treatments
Phoenix, Ariz. – Today, Governor Doug Ducey signed legislation that will ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. The new law will enable more Arizonans to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
Governor Walz Signs Legislation to Increase Access to Innovative Testing that Can Match Patients with Most Effective Treatments
SAINT PAUL, Minn. – Today, Governor Tim Walz signed legislation that will ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. The new law will enable more Minnesotans to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments
Sacramento, Calif. – June 21, 2022 – The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. If signed into law, Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
Surge in Breast Cancer Among Asian American, Pacific Islander Women Underscores Need for Improved Biomarker Testing Access in Hawaii
... Society Cancer Action Network’s (ACS CAN) campaign to connect patients with the right treatment at the right time through increasing access to biomarker testing in Hawaii. Breast cancer is the most common cancer diagnosed among women in the U.S. It is also the second-leading cause of death from ... cancer mortality rates continue to decrease thanks to advances in early detection and treatment, like targeted therapies based on the results of biomarker testing. In cancer, biomarkers are often used to help determine the best treatment for a patient. Testing involves the analysis of a ...
Cancer Advocates Urge California Governor to Sign Legislation Expanding Access to Biomarker Testing Needed for Many Innovative Treatments
Sacramento, Calif. – The California Legislature passed a bill last night that would ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which ... was introduced by Senator Monique Limón (D-Santa Barbara) – has received unanimous, bipartisan support throughout the legislative process. Biomarker testing is a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...
Calls to Improve Access to Biomarker Testing in NJ Bring Together Patients, Providers & Public Health Leaders across Disease Spectrum
Key public health, patient and provider groups have come out in support of improving access to biomarker testing in New Jersey, urging lawmakers to advance and pass Assembly Bill 4163 / Senate Bill 3098 this legislative session. This fall, a broad ... Institutions & Insurance (AFI) Committee to vote in favor of A4163, which they did—unanimously—several weeks ago. Now, the New Jersey Biomarker Coalition is looking to the Assembly Appropriations and Senate Commerce Committees to take up this bill and follow the lead of their AFI ...
Patient Advocates Rally in Times Square for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Legislation
... Earlier today, cancer survivors gathered in Times Square alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on Governor Hochul to sign Senate Bill 1196a / Assembly Bill 1673a and reject any attempts to weaken the bill by limiting its scope. Biomarker testing enables physicians to match patients with personalized care and improve patient quality of life by avoiding ineffective, invasive ...
New Study Underscores Importance of Pharmacogenomic Testing to Patients and Finds Many Aren’t Aware of the Benefits
... of the American Medical Association (JAMA) Network Open finds many patients aren’t made aware of the importance of pharmacogenomic (PGx) testing. A form of biomarker testing, PGx testing examines how variations in a patient’s inherited genes may impact how they respond to different drugs. PGx testing ... said they would be concerned moving forward with the treatment plan in the hypothetical situation without being offered a PGx test first. “Biomarker testing, including pharmacogenomic (PGx) testing, can play a crucial role in improving cancer outcomes and decreasing cancer disparities, ...
Calls to Improve New Yorkers’ Access to Precision Medicine Through Biomarker Testing Bring Together Patients and Providers from across Disease Spectrum
... seeks to improve New Yorkers’ access to precision medicine, requiring all state-regulated health plans, including Medicaid, to cover biomarker testing when it is supported by medical and scientific evidence. Over 60 organizations have rallied together in support of the legislation, citing the efficacy of and praising the innovation in precision medicine. Biomarker testing is a tool utilized by physicians across a variety of specialties to connect patients to the right treatment at the right time. ...
Type
- Action (3) Apply Action filter
- Basic page (54) Apply Basic page filter
- Blog Post (1) Apply Blog Post filter
- Event (10) Apply Event filter
- Press Release (183) Apply Press Release filter
- Resource (2) Apply Resource filter
- State Priority (36) Apply State Priority filter
- Update (9) Apply Update filter
- Webform (3) Apply Webform filter
Priority Issue
State
- New York (26) Apply New York filter
- Ohio (17) Apply Ohio filter
- Pennsylvania (17) Apply Pennsylvania filter
- California (15) Apply California filter
- New Jersey (14) Apply New Jersey filter
- Washington (14) Apply Washington filter
- Florida (10) Apply Florida filter
- Maine (10) Apply Maine filter
- Colorado (9) Apply Colorado filter
- Connecticut (9) Apply Connecticut filter
- Hawaii (9) Apply Hawaii filter
- Tennessee (9) Apply Tennessee filter
- Georgia (8) Apply Georgia filter
- Illinois (8) Apply Illinois filter
- Kentucky (8) Apply Kentucky filter
- Maryland (8) Apply Maryland filter
- Massachusetts (8) Apply Massachusetts filter
- North Carolina (8) Apply North Carolina filter
- National (7) Apply National filter
- Nevada (6) Apply Nevada filter
- Iowa (5) Apply Iowa filter
- New Hampshire (5) Apply New Hampshire filter
- Oregon (5) Apply Oregon filter
- Texas (5) Apply Texas filter
- Vermont (5) Apply Vermont filter
- West Virginia (5) Apply West Virginia filter
- Arizona (4) Apply Arizona filter
- Delaware (4) Apply Delaware filter
- Indiana (4) Apply Indiana filter
- Minnesota (4) Apply Minnesota filter
- Nebraska (4) Apply Nebraska filter
- New Mexico (4) Apply New Mexico filter
- Oklahoma (4) Apply Oklahoma filter
- Rhode Island (2) Apply Rhode Island filter
- Alaska (1) Apply Alaska filter
- Louisiana (1) Apply Louisiana filter
- Michigan (1) Apply Michigan filter
- South Dakota (1) Apply South Dakota filter